Literature DB >> 1166725

Structural studies of the Klebsiella type 57 capsular polysaccharide.

J P Kamerling, B Lindberg, J Lönngren, W Nimmich.   

Abstract

The structure of the capsular polysaccharide from Klebsiella type 57 has been investigated. Methylation analysis, uronic acid degradation, modified Smith degradation and graded acid hydrolysis were the principle methods used. Pure oligomeric fragments were isolated using the three methods of degradation and characterized by chemical and physical methods. These studies show the structure to consist of a tetrasaccharide repeating unit (all sugar residues have the D-configuration and are pyranosidic).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1166725     DOI: 10.3891/acta.chem.scand.29b-0593

Source DB:  PubMed          Journal:  Acta Chem Scand B        ISSN: 0302-4369


  4 in total

1.  Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype.

Authors:  Yi-Jiun Pan; Han-Chi Fang; Hui-Ching Yang; Tzu-Lung Lin; Pei-Fang Hsieh; Feng-Chiao Tsai; Yoav Keynan; Jin-Town Wang
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

Review 2.  Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.

Authors:  J E Choby; J Howard-Anderson; D S Weiss
Journal:  J Intern Med       Date:  2019-11-21       Impact factor: 8.989

3.  Identification of a capsular variant and characterization of capsular acetylation in Klebsiella pneumoniae PLA-associated type K57.

Authors:  Chun-Ru Hsu; Chun-Hsing Liao; Tzu-Lung Lin; Han-Ru Yang; Feng-Ling Yang; Pei-Fang Hsieh; Shih-Hsiung Wu; Jin-Town Wang
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

4.  A Bacteriophage-Acquired O-Antigen Polymerase (Wzyβ) from P. aeruginosa Serotype O16 Performs a Varied Mechanism Compared to Its Cognate Wzyα.

Authors:  Véronique L Taylor; Jesse F J Hoage; Sandra Wingaard Thrane; Steven M Huszczynski; Lars Jelsbak; Joseph S Lam
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.